NetworkNewsWire Editorial Coverage: A
momentous cultural and economic change is soon coming to Canada, as
the Canadian Government has committed to legalizing recreational
marijuana on July 1, 2018. Already busy with demand for medicinal
marijuana - which has been legal in Canada since 2001 - licensed
cultivators are ramping up their production capabilities in
anticipation of a staggering surge in demand. Investors are also
taking notice, in October driving average gains of 7.6% among
Canadian cannabis producers (http://nnw.fm/KJ29n). The Canadian Government is also
making preparations for the impending legalization, emphasizing
cannabis education and awareness for the nation’s youth (http://nnw.fm/b4U9O). This focus on health and safety
adds weight to the proprietary, organic and pesticide-free growing
systems of ABcann Global Corp. (OTCQB:
ABCCF) (TSX.V: ABCN) (ABCCF
Profile), which, thanks to a hefty investment by
Cannabis Wheaton Income Corp. (OTCQB:
CBWTF) (TSX.V: CBW), has the capital needed to increase
its supply. Other licensed producers gearing up to meet demand
Maricann Group, Inc. (OTCQB: MRRCF) (MARI:
CC), Emblem Corp. (OTC: EMMBF)
(EMC: CC) and MedReleaf Corp. (OTC: MEDFF) (LEAF:
CC).
The impending legalization of marijuana for recreational use in
Canada could offer licensed producers a chance to record tremendous
growth in the coming months. According to a 2016 report by
Deloitte, the legal Canadian marijuana market could soon be worth
$18 billion annually. As for volume, Deloitte forecast annual
demand for the plant at about 1.32 million pounds per year.
With a highly regulated system and strict licensing
requirements, the Canadian market is a safe haven for investors
looking to invest in quality products and companies in a market
brimming with potential. However, an overly strict licensing
process restricts supply, as seen in the U.S. State of Nevada
(http://nnw.fm/He1F0).
As a result, the Canadian government has relaxed its licensing
approval process, and established growers such as ABcann Global
Corp. (OTCQB: ABCCF) (TSX.V: ABCN) have a head start.
Focused on producing premium quality organic standardized medicinal
cannabis, ABcann has developed a proprietary computerized system to
control marijuana growing, which enables it to replicate the
cultivation environment of any geographical location in the world.
This level of control guarantees a consistent product of superior
quality that is repeatable from batch to batch, something that is
demanded by both physicians and patients. The company’s innovative
system uses controlled lighting, organic fertilizers and soil media
to deliver natural, safe products at high yields. Through strict
environmental control of temperature, humidity and water, ABcann is
able to eliminate the need for pesticides, which can taint
supply.
Cultivation requires capital, and with $40 million in the bank,
ABcann is especially well-positioned to increase its production
capabilities. A hefty portion of this cash is from a $30 million
with Cannabis Wheaton (OTCQB: CBWTF) (TSX.V: CBW)
to fund the construction of additional ABcann production
facilities.
ABcann currently operates a licensed 14,500-square-foot Vanluven
facility located in Napanee, Ontario, and the company is gearing up
to break ground on its new 150,000-square-foot Kimmet facility in
Napanee. Even with the new facility, ABcann has plenty of wiggle
room, as it also owns 65 acres of land for future development with
full infrastructure already in place, which will be able to
accommodate another growing facility estimated at 1.2 million
square feet.
Experienced leadership is part of what has helped ABcann earn
its stripes in the marijuana industry. At the helm of ABcann’s
expansion strategies is a strong management team led by Barry
Fishman, former CEO of Teva Canada, a producer of generics and
specialty pharmaceuticals generating $1 billion in revenue. Fishman
has a proven track record as CEO of three international companies
where he exhibited his exceptional abilities in deal-making,
mergers and acquisitions, and raising capital.
Fishman’s experience in international markets bodes well for
ABcann’s pursuit of achieving greater market share in Canada, along
with growth opportunities in Germany and other parts of Western
Europe, as well as in South America.
Though ABcann’s current market valuation is USD$80 million
(CAD$100.6+ million), the company’s capabilities place it among the
ranks of larger cultivators like Maricann Group (OTCQB:
MRRCF) (MARI: CC) in Langton, Ontario. Having established
itself as a respected supplier of medical cannabis, the company is
focusing on expanding all areas of operation, from cultivation to
extraction, analytics and production, with a view to developing
global markets. Health Canada recently granted to Maricann a new
license to increase its production capacity by over 480 percent to
6,250,000 grams. The company also recently entered a collaboration
agreement with a national provider of services to pharmacies to
create a special medical cannabis program for physicians and
patients. Maricann’s market cap is just more than USD$110
million.
In Paris, Ontario, licensed producer Emblem Corp. (OTC:
EMMBF) (EMC: CC) operates a facility that consists of six
controlled indoor growing rooms, with a seventh scheduled to be
added by spring 2018. As part of its expansion, Emblem is
completing the construction of a 30,000-square-foot facility
housing a GMP extraction laboratory as well as a value-added
product and pharmaceutical production facility. In October 2017,
the company entered an exclusive agreement with Canntab
Therapeutics to collaborate on the preclinical formulation,
development, manufacturing and commercialization of a
cannabinoid-based oral sustained release formulation for the
treatment of chronic pain, nausea and spasticity in patients with
multiple sclerosis. Emblem’s market valuation is USD$1 million
(CAD$116+ million).
MedReleaf Corp. (OTC: MEDFF) (LEAF: CC) is a
licensed producer, in addition to being the only ISO 9001 certified
medical cannabis producer in North America. This is a quality
management standard set by the International Standards Organization
(ISO) and requires certified companies to adhere to strict quality
control and assurance procedures. With a market cap of over USD$1.2
billion (CAD $1.5+ billion), MedReleaf has state-of-the-art
marijuana growing facilities in Ontario and uses proprietary plant
breeding programs and advanced cultivation methodologies. The
company also conducts research and development into the therapeutic
benefits of cannabis and manufactures a range of premium medical
cannabis products.
By forming strategic partnerships to grow their facilities,
these licensed producers are well positioned to meet increased
demand for Canada’s supply-hungry marijuana market, and with more
than 65 acres of growth capacity, a healthy cash balance to fund
upcoming construction efforts, steady sales growth,
industry-leading yield rates, and an established operations team in
place, ABcann is well-positioned as market leader.
For more information on ABcann Global Corp., visit ABcann Global
Corp. (OTCQB: ABCCF) (TSX.V: ABCN).
About NetworkNewsWire
NetworkNewsWire (NNW) is an information service that provides
(1) access to our news aggregation and syndication servers, (2)
NetworkNewsBreaks that summarize corporate news and
information, (3) enhanced press release services, (4) social media
distribution and optimization services, and (5) a full array of
corporate communication solutions. As a multifaceted financial news
and content distribution company with an extensive team of
contributing journalists and writers, NNW is uniquely positioned to
best serve private and public companies that desire to reach a wide
audience of investors, consumers, journalists and the general
public. NNW has an ever-growing distribution network of more than
5,000 key syndication outlets across the country. By cutting
through the overload of information in today’s market, NNW brings
its clients unparalleled visibility, recognition and brand
awareness. NNW is where news, content and information converge.
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com
Please see full terms of use and disclaimers on the
NetworkNewsWire website applicable to all content provided by NNW,
wherever published or re-published: http://NNW.fm/Disclaimer
DISCLAIMER: NetworkNewsWire (NNW) is the source of the Article
and content set forth above. References to any issuer other than
the profiled issuer are intended solely to identify industry
participants and do not constitute an endorsement of any issuer and
do not constitute a comparison to the profiled issuer. The
commentary, views and opinions expressed in this release by NNW are
solely those of NNW. Readers of this Article and content agree that
they cannot and will not seek to hold liable NNW for any investment
decisions by their readers or subscribers. NNW are a news
dissemination and financial marketing solutions provider and are
NOT registered broker-dealers/analysts/investment advisers, hold no
investment licenses and may NOT sell, offer to sell or offer to buy
any security.
The Article and content related to the profiled company
represent the personal and subjective views of the Author, and are
subject to change at any time without notice. The information
provided in the Article and the content has been obtained from
sources which the Author believes to be reliable. However, the
Author has not independently verified or otherwise investigated all
such information. None of the Author, NNW, or any of their
respective affiliates, guarantee the accuracy or completeness of
any such information. This Article and content are not, and should
not be regarded as investment advice or as a recommendation
regarding any particular security or course of action; readers are
strongly urged to speak with their own investment advisor and
review all of the profiled issuer’s filings made with the
Securities and Exchange Commission before making any investment
decisions and should understand the risks associated with an
investment in the profiled issuer’s securities, including, but not
limited to, the complete loss of your investment.
NNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.
This release contains “forward-looking statements” within the
meaning of Section 27A of the Securities Act of 1933, as amended,
and Section 21E the Securities Exchange Act of 1934, as amended and
such forward-looking statements are made pursuant to the safe
harbor provisions of the Private Securities Litigation Reform Act
of 1995. “Forward-looking statements” describe future expectations,
plans, results, or strategies and are generally preceded by words
such as “may”, “future”, “plan” or “planned”, “will” or “should”,
“expected,” “anticipates”, “draft”, “eventually” or “projected”.
You are cautioned that such statements are subject to a multitude
of risks and uncertainties that could cause future circumstances,
events, or results to differ materially from those projected in the
forward-looking statements, including the risks that actual results
may differ materially from those projected in the forward-looking
statements as a result of various factors, and other risks
identified in a company’s annual report on Form 10-K or 10-KSB and
other filings made by such company with the Securities and Exchange
Commission. You should consider these factors in evaluating the
forward-looking statements included herein, and not place undue
reliance on such statements. The forward-looking statements in this
release are made as of the date hereof and NNW undertake no
obligation to update such statements.
Source:
NetworkNewsWire
Contact:
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com
Auxly Cannabis (QB) (USOTC:CBWTF)
Historical Stock Chart
From Oct 2024 to Nov 2024
Auxly Cannabis (QB) (USOTC:CBWTF)
Historical Stock Chart
From Nov 2023 to Nov 2024
